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A B S T R A CT  
Hereditary pancreatitis (HP) is a rare heterogeneous disease with partial penetrance identified by 
frequent episodes of severe abdominal pain, often showing in young aged children. It is complicating 
by chronic pancreatitis, and high rate of pancreatic cancer (up to 40-50%). The aim of this work was 
to classify the most deleterious mutation in PRSS1 gene and to predict their influence on the functional 
and structural level by a variety of bioinformatics analysis tools. The raw data of PRSS1 gene were 
recovered from SNP database, and further used to examine a deleterious effect using SIFT, PolyPhen-
2, PROVEAN, SNAP2, SNPs&GO, PHD-SNP, PANTHER and P-Mut. The functional analysis 
predicted that two SNPs “rs1366278558 and rs767036052” have a deleterious effect at functional level. 
Additionally, we submitted them to I-mutant 3.0, and MUPro respectively to investigate their effect on 
structural level; the two tools revealed that; two mutations have a dramatic decrease of the protein 
stability, thus suggesting that the M1R and L4P mutations of PRSS1  gene could destabilize the amino 
acid interactions causing functional abnormalities of PRSS1 protein. The 3D structure of PRSS1 was 
predicted by RaptorX and modeled using UCSF Chimera to compare the differences between the 
native and the mutant amino acids. From the comparative analysis at the functional and structural level, 
these two SNPs “M1R and L4P” have a deleterious effect and thus could be used as diagnostic markers 
to predict HP. These findings can be used as a platform to develop large-scale studies in the future. 
Keywords: Hereditary pancreatitis, Pancreatic Cancer, Bioinformatics Approach, Single-nucleotide polymorphisms, PRSS1. 
1 Introduction 
Hereditary pancreatitis (HP) is a rare 
heterogeneous disease with partial penetrance 
characterized by recurrent severe abdominal pain 
that manifest on juvenile age children. 
Progression to chronic pancreatitis is common 
with high rate of pancreatic malignancy (up to 40-
50%) with almost 80% penetrance and flexible 
fluency.[1-5] The first warning sign appears early   
before 10 years old, upon which they will be 
mainly complaining of pancreatic pain (>70%). 
morphological variations as pancreatic 
calcifications are diagnosed at early age of 22-25 
years. Exocrine and endocrine pancreatic 
deficiency happened in 34% and 26% of 
patients.[6, 7] The first family   documented to 
have hereditary pancreatitis was described in 
1952.[8, 9] after that about 100 families have been 
reported  [4], which they were encountered by 
physicians in different countries [3, 10-16]. HP is 
a progressive inflammatory disease in which 
pancreatic secretory parenchyma is destroyed and 
replaced by fibrous tissue [17], as the disease 
progress it will eventually lead to malnutrition 
and diabetes.[18] Several studies show that; 
patients with HP have a significantly elevated risk 
of developing pancreatic cancer when compared 
with the overall people up to 40-50%[1, 16, 19-
22], Also cigarette Smoking were found to rise 
the possibility factor for developing pancreatic 
malignancy in Patients suffering from Hereditary 
Pancreatitis.[23, 24] 
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Currently, there is no effective medical treatment 
for HP, but it can be managed by pancreatic 
enzyme replacement therapy along with 
analgesics to control the pain. In addition, 
endoscopic retrograde cholangiopancreato-
graphy (ERCP) and surgical intersections are 
reserved for complicated cases.[25-31] 
HP has mainly been related with mutations in the 
serine protease 1 gene (PRSS1). It has been 
mapped to chromosome 7 q35.[5, 20] Among all 
genes that was mentioned in the literature to have 
associations with hereditary pancreatitis PRSS1 
gene is the most reported one [1, 5-7, 15, 26, 30, 
32-36], PRSS1 gene are found to encode human 
cationic trypsinogen. Furthermore Most high 
penetrance PRSS1 modifications will increase 
intra pancreatic trypsin activity. [37] Interestingly, 
mutations in PRSS1 gene may protect against the 
disease.[38, 39] In several studies (R122H), 
mutation in PRSS1 gene was strongly associated 
with hereditary pancreatitis [6, 25, 32, 40, 41]. The 
genetic makeup of the mutation in PRSS1 gene 
and full pathogenesis of by which it causes the 
disease is still unclear.[5] In vitro functional and 
characterization studies, is a highly demanding 
task in terms of workload, time and financial cost. 
For these reasons, computational analysis is an 
appropriate alternative that is more rapid and  
low-cost  approach, which is why it has been used 
to study many types of inheritance diseases in the 
past years [42-44] to enrich our knowledge of the 
ways   mutations could affect  protein structure 
and function. The main objective of this work 
was to classify the most damaging SNPs that 
could be used as diagnostic markers. An 
extensive in silico approach using multiple 
software was used in this study, our result can be 
used as a platform to develop larger-scale studies 
in the future. 
2 Materials and Methods 
2.1 Data mining 
The raw data of PRSS1 gene were retrieved from 
NCBI website by selecting the gene view from 
the main result page then downloading the 
resulted table in to an excel sheet[45], 
furthermore the protein reference sequence was 
collected from Uniprot[46]  
2.2 Functional Investigation of Damaging 
SNPs 
2.2.1 SIFT 
Is the first in silico method for functional 
analysis, which calculates whether an amino acids 
alteration change protein function, or not. SIFT 
scores < 0.05 are expected to be damaging altered 
amino acid, otherwise it considered to be 
tolerant.[47, 48] from the single protein tools we 
choose sift sequence, then we inserted our 
reference sequence with the original parameters 
unchanged and download the resulting values. 
The disadvantage about this tool is the inability 
to provide result for two sequence variations with 
the identical position in the same time. 
2.2.2 Polyphen-2 
It’s a trained machine learning to predict the 
possible effect of amino acid replacement on 
protein function and structure, by calculating 
Position Specific Independent Count (PSIC) for 
each SNP at the time. It provides accurate 
predictions with three possible output whether 
probably damaging (values are more rapidly to 
one), possibly damaging or benign (values are 
varieties from zero to 0.95.) [49, 50] we inserted 
the amino acid sequences after preparing it as the 
web site specification in to the batch query area 
on the site.  
2.2.3 PROVEAN 
It’s very fast and accurate online in silico 
functional analysis tool that calculates whether 
specific amino acid replacement has an effect on 
the biological function of a protein depending on 
the alignment-based score. PROVEAN 
probability has two possibilities, deleterious or 
neutral with cutoff -2.5.[51] we choose (provean 
protein) choice from the web side and then 
inserted the reference sequence along with the 
amino acid variations without changing the 
parameter. Like SIFT, it can help the researcher 
identify mistakes in preparing the amino acid 
variations. 
2.2.4 SNAP2 
It is a trained functional analysis tool that 
differentiates between effect and neutral SNPs by 
taking a variety of features into validation.  It 
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consumes more time to work with the result than 
other tools and it got an accuracy of 83%, with 
two expectations, effect (positive score) or 
neutral (negative score). But it still considered an 
important and substantial enhancement over 
other methods. [52]we  directly run the prediction 
after entering the  reference protein sequence. 
2.2.5 SNPs & GO 
It is a trained machine learning based on the 
technique to precisely calculate the deleterious 
associated alterations from protein sequence. 
SNPs&GO collects in unique framework 
information derived from protein sequence, 
evolutionary information, and function as coded 
in the Gene Ontology terms. SNPs&GO 
performs other prediction methods (PHD-SNP 
and PANTHER) [53] we uploaded both the 
reference sequence and  the amino acid variations 
then submit them and downloaded the result . 
The website provides friendly user environment 
with fast and reliable result. 
2.2.6  P-Mut 
It is a web-based tool for the explanation of SNPs 
alternates on proteins; it is characterized by fast 
and precise calculation. The mutations can be 
predicted to be either Neutral or disease causing. 
[54] we analyses the sequence and the variations 
through (analyzing mutations ) link on the web 
side using PMut2017 predictor. 
2.3 Stability Investigation 
2.3.1 I-Mutant 3.0 
It’s a structural analysis online tool for the routine 
analysis of protein stability   by considering the 
single-site alterations. Negative I-Mutant scores 
are expected to decrease the protein stability, 
otherwise (positive) it considered to increase 
it.[55] It is relatively easy to use website. We 
selected the (protein sequence) category that is 
related to (Prediction of protein stability changes 
upon single point mutations) then we inserted the 
reference sequence, the position and the residue 
and highlighted the (DDG value and binary 
classification method) before finally submitting 
these inputs. 
2.3.2 MUPro                                                                                                                                   
 It is a structural analysis online tool for the 
calculation of protein stability variations upon 
arbitrarily SNPs. The value of the energy change 
is expected, and assurance mark between -1 and 
one for evaluating the assurance of the 
expectation is calculated. A score < 0 means the 
mutant decreases the protein stability; conversely, 
a score > 0 means the mutant increases the 
protein stability.[56]  
2.4 ConSurf server 
It is a web server offers evolutionary 
conservation summaries for proteins of known 
structure in the protein data bank. ConSurf spot 
the parallel amino acid sequences and run multi 
alignment methods. The conserved amino acid 
across species detects its position using specific 
algorisms.[57, 58]  
2.5 BioEdit 
It is a software package proposed to stream a 
distinct program that can run nearly any 
sequences operation as well as a few basic 
alignment investigations.[59] The FASTA format 
sequences of PRSS1 protein were retrieved from 
UniProt and used as an input to locate and 
determine if the SNPs are located at conserved 
sites or not. Through ClustalW choice in the 
accessory applications. 
2.6 GeneMANIA 
It is a method to identify protein function and 
gene - gene interactions; it integrates multiple 
genomics and proteomics data to create reliable 
information about the function of unknown 
proteins, although some time it fails to know the 
functions of some proteins.[60] we inserted the 
gene name then we download the relevant result 
into an excel sheet. 
2.7 3D Clustering Analysis 
2.7.1  Mutation3D 
It is a functional calculation and visualization 
online tool for investigating the three-
dimensional plan of amino acid alterations on 
protein models and structures. The input formats 
were the gene name and the SPNs of interest. [61]  
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2.8 Biophysical Validation & 
Visualization analysis  
2.8.1 Project HOPE 
It is a webserver to search protein 3D structures 
by bringing together structural information from 
several sources such as UniProt database. The 
main aims for the submissions in Project HOPE 
are to analysis and confirm results that we had it 
earlier. [62] we upload the sequence without the 
identifications line then we defined the positions 
with the related amino acids. The advantage in 
using Project HOPE is the detailed information 
provided for each SNPs variation, but the main 
disadvantage would be the delay in the results 
that sometimes occurs for hours. 
2.8.2 Displaying Amino Acid Mutations 
For this task we used UCSF Chimera, It’s for 
visualization and investigation of SNPs at the 
molecular level. Protein in Pdb format can be 
viewed by UCSF Chimera to scan the native and 
the mutant amino acids to observe the alterations 
that occur. [63] we study the structural changes 
mainly through (structure editing and rotamers ) 
tools in the chimera software . 
2.9 Variant Effect Predictor (VEP) 
The Ensembl Variant Effect Predictor software 
provides toolsets for an organized approach to 
annotate and aid prioritization of variants in both 
large-scale sequencing projects and smaller 
analysis studies.[64]  
3 Results and Discussion 
3.1 Results 
Data related to the total number of SNPs in 
different regions of PRSS1 gene was retrieved 
from dbSNP database with the distribution of 
SNPs in coding and non-coding regions of 
PRSS1 gene (figure 1). Out of 911 SNPs there are 
506 SNPs, contained 339 nsSNPs, 133 
synonymous, 17 frame shit and 17 nonsense, with 
26 in the 3′-UTR region and 11 in the 5′-UTR 
region (figure 2).  
Figure 2: Graphic representation of PRSS1 gene 
workflow. 
 
Figure 1: the distribution of SNPs in coding and non-coding regions of PRSS1 gene. 
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These 339 nsSNPs were used to examine the 
deleterious effect on the associated protein. To 
identify the most deleterious nsSNPs, we toke the 
combined deleterious results from 8 functional 
tools, only the highly deleterious SNPs by SIFT, 
PolyPhen, PROVEAN, SNAP2, SNPs&GO, 
PHD-SNP, PANTHER and P-Mut, meet the 
criteria as illustrated in (Table 1,2 and 3). 
Remarkably, only two SNPs (M1R and L4P) give 
positive results with all the tools.  
Table 1: Shows the affected SNPs that investigate by several online tools (*SUB: Substitutions (variants)) 
dbSNP rs# SUB         SIFT    Polyphen         PROVEAN    SNAP2   
    prediction Score    prediction Score  Prediction Score prediction Score 
rs1366278558 M1R Damaging 0  probably damaging 1 Deleterious -4.183 effect 51 
rs780969708 C30W Damaging 0  probably damaging 1 Deleterious -9.449 effect 66 
rs769459903 P36R Damaging 0  probably damaging 1 Deleterious -7.82 effect 59 
rs138464021 G49D Damaging 0  probably damaging 1 Deleterious -6.273 effect 90 
- G49V Damaging 0  probably damaging 1 Deleterious -8.061 effect 87 
- L52F Damaging 0  probably damaging 1 Deleterious -3.628 effect 32 
rs149246646 I53N Damaging 0  probably damaging 1 Deleterious -6.266 effect 68 
rs778570468 W57G Damaging 0  probably damaging 1 Deleterious -11.76 effect 83 
rs1338646513 W57C Damaging 0  probably damaging 1 Deleterious -11.77 effect 63 
rs1192452565 V58G Damaging 0  probably damaging 1 Deleterious -6.083 effect 73 
rs370761165 A61E Damaging 0  probably damaging 1 Deleterious -4.397 effect 80 
rs372411481 G83R Damaging 0  probably damaging 1 Deleterious -7.011 effect 40 
- G83W Damaging 0  probably damaging 1 Deleterious -7.169 effect 5 
rs1268805560 H96Y Damaging 0  probably damaging 1 Deleterious -5.652 effect 72 
rs1209409723 H96Q Damaging 0  probably damaging 1 Deleterious -7.515 effect 78 
rs1454816504 Y99C Damaging 0  probably damaging 1 Deleterious -8.117 effect 72 
rs1323769980 D107Y Damaging 0  probably damaging 1 Deleterious -8.448 effect 94 
rs1426710453 L113H Damaging 0  probably damaging 1 Deleterious -6.567 effect 79 
rs144403091 V123M Damaging 0  probably damaging 1 Deleterious -2.664 effect 21 
rs749518244 L128Q Damaging 0  probably damaging 1 Deleterious -5.698 effect 49 
- L128P Damaging 0  probably damaging 1 Deleterious -6.649 effect 74 
rs768673799 P129H Damaging 0  probably damaging 1 Deleterious -8.254 effect 45 
rs748208676 I141N Damaging 0  probably damaging 1 Deleterious -6.392 effect 89 
rs1164996242 S142P Damaging 0  probably damaging 1 Deleterious -4.777 effect 86 
rs1164331073 W144C Damaging 0  probably damaging 1 Deleterious -12.47 effect 80 
rs1221038304 G145R Damaging 0  probably damaging 1 Deleterious -7.632 effect 91 
rs1172272446 C160R Damaging 0  probably damaging 1 Deleterious -11.07 effect 28 
rs778796800 C160Y Damaging 0  probably damaging 1 Deleterious -10.15 effect 22 
- C160F Damaging 0  probably damaging 1 Deleterious -10.15 effect 41 
rs200973660 C171Y Damaging 0  probably damaging 1 Deleterious -10.21 effect 80 
- C171S Damaging 0  probably damaging 1 Deleterious -9.272 effect 78 
rs756821075 Y175N Damaging 0  probably damaging 1 Deleterious -8.298 effect 75 
- Y175H Damaging 0  probably damaging 1 Deleterious -4.616 effect 66 
rs1217657614 D194V Damaging 0  probably damaging 1 Deleterious -8.36 effect 85 
rs763907908 C196G Damaging 0  probably damaging 1 Deleterious -11.15 effect 93 
rs1412477456 G201R Damaging 0  probably damaging 1 Deleterious -7.194 effect 87 
rs1288010897 G201V Damaging 0  probably damaging 1 Deleterious -8.04 effect 83 
rs1289842951 P203H Damaging 0  probably damaging 1 Deleterious -8.323 effect 65 
rs747422004 V205D Damaging 0  probably damaging 1 Deleterious -5.836 effect 81 
rs1366495669 S215P Damaging 0  probably damaging 1 Deleterious -4.618 effect 93 
rs1481112469 C220W Damaging 0  probably damaging 1 Deleterious -10.13 effect 90 
rs1164573795 P226S Damaging 0  probably damaging 1 Deleterious -7.318 effect 63 
rs1309672836 Y229H Damaging 0  probably damaging 1 Deleterious -4.582 effect 85 
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Table 2: List of SNPs analyzed for disease association by three online servers (*RI: Reliability Index) 
dbSNP rs# Mutation 
PHD-
SNP 
Prediction  
RI Probability 
SNP &Go 
Prediction 
RI Probability 
 
PANTHER 
Prediction 
RI Probability 
rs1366278558 M1R Disease 0 0.514 Disease 3 0.668 Disease 9 0.95 
rs780969708 C30W Disease 6 0.825 Disease 7 0.848 Disease 10 0.99 
rs769459903 P36R Disease 4 0.708 Disease 1 0.558 Disease 5 0.734 
rs138464021 G49D Disease 8 0.917 Disease 7 0.862 Disease 8 0.88 
- G49V Disease 8 0.913 Disease 7 0.852 Disease 8 0.902 
- L52F Disease 7 0.841 Disease 6 0.783 Disease 9 0.954 
rs149246646 I53N Disease 8 0.888 Disease 7 0.844 Disease 8 0.891 
rs778570468 W57G Disease 8 0.897 Disease 6 0.787 Disease 10 0.98 
rs1338646513 W57C Disease 9 0.942 Disease 7 0.849 Disease 10 0.993 
rs1192452565 V58G Disease 6 0.818 Disease 4 0.695 Disease 7 0.848 
rs370761165 A61E Disease 8 0.891 Disease 5 0.762 Disease 6 0.779 
rs372411481 G83R Disease 3 0.67 Disease 3 0.667 Disease 4 0.715 
- G83W Disease 5 0.756 Disease 4 0.687 Disease 9 0.952 
rs1268805560 H96Y Disease 8 0.879 Disease 5 0.741 Disease 4 0.695 
rs1209409723 H96Q Disease 7 0.867 Disease 5 0.728 Disease 3 0.673 
rs1454816504 Y99C Disease 7 0.867 Disease 5 0.756 Disease 9 0.927 
rs1323769980 D107Y Disease 9 0.933 Disease 7 0.829 Disease 9 0.973 
rs1426710453 L113H Disease 8 0.905 Disease 5 0.765 Disease 9 0.935 
rs144403091 V123M Disease 0 0.511 Disease 0 0.507 Disease 4 0.681 
rs749518244 L128Q Disease 5 0.753 Disease 4 0.7 Disease 7 0.869 
- L128P Disease 5 0.765 Disease 4 0.7 Disease 8 0.902 
rs768673799 P129H Disease 3 0.66 Disease 1 0.545 Disease 7 0.845 
rs748208676 I141N Disease 6 0.794 Disease 6 0.823 Disease 7 0.87 
rs1164996242 S142P Disease 6 0.812 Disease 7 0.853 Disease 6 0.817 
rs1164331073 W144C Disease 9 0.929 Disease 6 0.805 Disease 8 0.918 
rs1221038304 G145R Disease 7 0.866 Disease 6 0.812 Disease 9 0.966 
rs1172272446 C160R Disease 5 0.757 Disease 8 0.876 Disease 10 0.987 
rs778796800 C160Y Disease 3 0.674 Disease 7 0.834 Disease 10 0.992 
- C160F Disease 5 0.76 Disease 7 0.866 Disease 10 0.99 
rs200973660 C171Y Disease 8 0.925 Disease 7 0.827 Disease 10 1 
- C171S Disease 8 0.895 Disease 5 0.772 Disease 10 1 
rs756821075 Y175N Disease 7 0.835 Disease 4 0.698 Disease 7 0.873 
- Y175H Disease 3 0.661 Disease 2 0.589 Disease 6 0.806 
rs1217657614 D194V Disease 8 0.904 Disease 7 0.872 Disease 8 0.898 
rs763907908 C196G Disease 6 0.816 Disease 5 0.743 Disease 10 0.999 
rs1412477456 G201R Disease 8 0.882 Disease 7 0.839 Disease 7 0.849 
rs1288010897 G201V Disease 8 0.906 Disease 7 0.855 Disease 7 0.84 
rs1289842951 P203H Disease 7 0.835 Disease 4 0.701 Disease 10 0.979 
rs747422004 V205D Disease 7 0.831 Disease 6 0.775 Disease 8 0.903 
rs1366495669 S215P Disease 8 0.878 Disease 7 0.827 Disease 6 0.804 
rs1481112469 C220W Disease 9 0.928 Disease 7 0.855 Disease 9 0.967 
rs1164573795 P226S Disease 7 0.871 Disease 6 0.787 Disease 9 0.933 
rs1309672836 Y229H Disease 6 0.795 Disease 1 0.573 Disease 5 0.742 
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Table 3: Show a List of SNPs investigated by P-Mut 
dbSNP rs# Amino Acid change  P-mut Prediction  P-mut Score 
rs1366278558 M1R Decrease 0.78 (88%) 
rs767036052 L4P Decrease 0.70 (86%) 
Table 4: Structural Investigation predicted by using I-Mutant v3.0 and MUPro 
dbSNP rs# 
Amino 
Acid 
change 
 SVM2 
Prediction 
Effect 
RI 
DDG Value 
Prediction 
MUPro 
Prediction 
MUPro 
Score 
rs1366278558 M1R Decrease 1 -0.62 Decrease -1.0183 
rs767036052 L4P Decrease 8 -1.66 Decrease -1.6239 
*SVM: Support Vector Machine.   *DDG Value: free energy changes value. 
 
Further additional analysis were held for only 
these 2 SNPs.we submitted them to I-mutant 3.0, 
and MUPro respectively to investigate their effect 
on the structural level; the two tools revealed that, 
there is a dramatic decrease in  the protein 
stability, thus suggesting that the M1R and L4P 
mutations of PRSS1 could destabilize the amino 
acid interactions causing functional abnormalities 
of PRSS1 protein. (Table 4) 
3.2 Discussion 
Two mutations were predicted to have a potential 
major impact on the structure and function of the 
PRSS1 protein by using different computational 
analysis tools (Figure 2). The approaches used 
were grounded on different characteristics and 
limitations that unmask the pathogenicity and 
deliver evidences about the influence of each 
mutation. In the past years in silico analysis has 
been done for several inherited diseases and 
tumor associated genes along with other 
disorders. [43, 65, 66] in this study we used 
computational in silico analysis of PRSS1 gene to 
study nsSNP effect on the PRSS1 protein that 
could lead to the development of Hereditary 
Pancreatitis  . These SNPs were submitted to 
SIFT, PolyPhen, PROVEAN, and SNAP2 sever; 
we found 141 SNPs   to be damaging by SIFT. In 
PolyPhen2, the results showed that 170 SNPs 
were found to be damaging (54 possibly 
damaging and 116 probably damaging showed 
deleterious). In PROVEAN server our result 
showed that 203 SNPs were predicted to be 
deleterious. While in SNAP2 server the result 
showed that 172 SNPs were predicted to be 
deleterious. The alterations in calculation abilities 
and result are likely duo to the fact that every 
prediction algorithm uses different sets of 
sequences and alignments. we submitted the four 
positive combined SNPs results from SIFT, 
PolyPhen-2, PROVEAN and SNAP2 (Table 1) 
to be analyzed further by disease related 
softwares: SNPs & GO, PHD-SNP, 
PANTHER(Table2), P-Mut and MUPro servers. 
There was (85, 95 and 90) SNPs founded to be 
disease related by SNPs & GO, PHD-SNP and 
PANTHER servers respectively. While MUPro 
servers revealed different and unique results of 
only 2 disease related SNPs as shown in (Table3). 
We selected only the four positive combined 
results (disease-causing SNPs). (Figure 3) 
illustrate the relation between these soft wares. 
Additionally, we performed analysis by 
Mutation3D; our result shows that: (L4P) located 
in a domain, which indicates its vital significance 
(Figure 4). 
 
 
Figure 3: Shows Illustration of damaging 
mutations predicted by numerous of tools. 
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Figure 4: Screenshot for (L4P) shows high-
possibility SNP in its domain. 
The 3D protein structure analysis enables 
mapping of amino acid substitutions and, 
therefore, RaptorX was used to make a 3D 
structure model for PRSS1 protein (Figure 5).  
Figure 5: The 3D structure of PRSS1 protein 
model was generated by using RaptorX. 
To supports and matches the results acquired 
from different computational tools, we used 
UCSF Chimera. (Figure 6-7) shows the 
differences between native and mutant amino 
acids illustrated here in the green and red boxes. 
The schematic structures of the native amino 
acids are in the left side and the mutant ones are 
in the right side. The backbone, which is the same 
for each amino acid, is colored red and the side 
chain, unique for each amino acid is colored 
black, the 3D wide type residues colored green 
and mutant ones colored red, while the protein is 
colored dark gray. Project HOPE server was used 
to submit the two most deleterious nsSNPs 
(M1R) and (L4P). (rs1366278558): (M1R):  
Methionine changed to Arginine at position 1. As 
showed in (Figure 6)   this may decrease the 
protein stability which disrupts the amino acid 
interactions. (rs767036052):(L4P): Leucine 
residue changed to Proline at position 4. As 
showed in (Figure 7)   the altered remain is 
smaller; this may cause loss of interactions. 
Figure 6: Shows Methionine changes to Arginine 
at position 1. 
Figure 7: Shows Leucine changes to Proline at 
position 4. 
We also used ConSurf to flag the SNPs that are 
sited at highly conserved amino acid positions, 
which has a tendency be more damaging than 
SNPs that are sited at non- preserved positions. 
Our ConSurf analysis unmasked that (L4P) 
mutation was found in highly conserved site and 
expected to have a high influence on PRSS1 
104 
 
 ISSN: 2456-7132  
Available online at Journals.aijr.in 
Mustafa et al., Int. Ann. Sci.; Vol. 8, Issue 1, pp: 96-113, 2020 
protein structure and function as illustrated in 
(Figure 8).  To confirm our findings on (M1R & 
L4P) mutations, we used BioEdit (version 7.2.5) 
where Alignment of 10 amino acid arrangements 
of PRSS1 confirm their conservation and hence 
significance as evident in (Figure 9). 
GeneMANIA revealed that PRSS1 has many vital 
functions: blood microparticle, cobalamin 
metabolic process, extracellular matrix 
organization, extracellular structure organization, 
serine hydrolase activity, serine-type 
endopeptidase activity, serine-type peptidase 
activity. The associated genes contribute to 
accomplish similar function were demonstrated 
by GeneMANIA. on (Figure 10) and (Table 5-6). 
The VEP annotates variants using a wide range 
of reference data. That include transcripts, 
regulatory regions, and frequencies from 
previously observed variants, citations, clinical 
significance information, and predictions of 
biophysical consequences of variants , and that 
what makes VEP  give accurate results [64].  
 
Figure 8: Shows the conserved amino acids across species in PRSS1 protein were determined using Consurf. 
(e) An exposed residues according to the neural-network algorithm via an orange letter. (b) Residues predicted 
to be buried are demonstrated via a green letter. (f) A predicted functional residues (highly conserved and 
exposed) are indicated with a red letter. (s) A predicted structural residues (highly conserved and buried) that 
are demonstrated with a blue letter. (?) Insufficient data- the calculation for this site was performed on less than 
10% of the sequences are demonstrated via a yellow letter. 
Figure 9:  Alignment of 10 amino acid sequences of PRSS1 demonstrating that the residues predicted to be 
mutated (indicated by red arrows) are evolutionarily conserved across species. 
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Figure 10: Shows the relations between PRSS1 and its associated genes. 
Table 5: PRSS1 gene functions and its appearance in network and genome 
Function FDR 
Genes in 
network 
Genes in 
genome 
serine-type endopeptidase inhibitor activity 0.001356361 4 44 
renal system process involved in regulation of systemic arterial blood pressure 0.001356361 3 13 
regulation of hemostasis 0.001356361 4 54 
regulation of coagulation 0.001356361 4 56 
regulation of blood coagulation 0.001356361 4 54 
regulation of wound healing 0.003496886 4 74 
platelet activation 0.006856052 5 211 
endopeptidase inhibitor activity 0.007599469 4 99 
endopeptidase regulator activity 0.007599469 4 102 
peptidase inhibitor activity 0.007599469 4 101 
blood microparticle 0.008676071 4 108 
regulation of endopeptidase activity 0.009340491 5 251 
regulation of peptidase activity 0.009856636 5 258 
peptidase regulator activity 0.013382385 4 128 
renal system process 0.013666888 3 45 
endocrine process 0.013666888 3 42 
negative regulation of endopeptidase activity 0.013666888 4 140 
regulation of blood vessel size 0.013666888 3 44 
regulation of tube size 0.013666888 3 44 
negative regulation of peptidase activity 0.013666888 4 142 
regulation of systemic arterial blood pressure 0.013666888 3 43 
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platelet alpha granule lumen 0.01586832 3 48 
vascular process in circulatory system 0.028313203 3 59 
platelet alpha granule 0.029997483 3 61 
secretory granule lumen 0.030241005 3 62 
serine-type endopeptidase activity 0.033116705 3 67 
killing of cells of other organism 0.033116705 2 10 
exocytosis 0.033116705 4 191 
disruption of cells of other organism 0.033116705 2 10 
glomerular filtration 0.037840129 2 11 
renal filtration 0.037840129 2 11 
vesicle lumen 0.040192639 3 76 
enzyme inhibitor activity 0.040192639 4 214 
protein kinase C-activating G-protein coupled receptor signaling pathway 0.040192639 2 12 
cytoplasmic membrane-bounded vesicle lumen 0.040192639 3 76 
positive regulation of collagen metabolic process 0.044298773 2 13 
positive regulation of collagen biosynthetic process 0.044298773 2 13 
regulation of blood pressure 0.044298773 3 81 
platelet degranulation 0.044771122 3 82 
positive regulation of ERK1 and ERK2 cascade 0.04525757 3 83 
negative regulation of multicellular organismal process 0.045315882 4 230 
positive regulation of coagulation 0.048108433 2 15 
negative regulation of hydrolase activity 0.048108433 4 242 
collagen metabolic process 0.048108433 3 87 
positive regulation of hemostasis 0.048108433 2 15 
positive regulation of blood coagulation 0.048108433 2 15 
positive regulation of multicellular organismal metabolic process 0.048108433 2 15 
multicellular organismal macromolecule metabolic process 0.049591958 3 91 
regulation of endocrine process 0.051022071 2 16 
regulation of collagen biosynthetic process 0.051022071 2 16 
tissue homeostasis 0.051393559 3 94 
zymogen activation 0.052534202 3 97 
regulation of collagen metabolic process 0.052534202 2 17 
multicellular organismal metabolic process 0.052534202 3 97 
positive regulation of release of sequestered calcium ion into cytosol 0.052534202 2 17 
serine-type peptidase activity 0.052961891 3 98 
serine hydrolase activity 0.055058507 3 101 
cellular metal ion homeostasis 0.055058507 4 264 
positive regulation of Ras protein signal transduction 0.055058507 2 18 
collagen biosynthetic process 0.057743853 2 19 
multicellular organismal homeostasis 0.057743853 3 105 
regulation of multicellular organismal metabolic process 0.057743853 2 19 
positive regulation of small GTPase mediated signal transduction 0.057743853 2 19 
cobalamin metabolic process 0.0619817 2 20 
fibrinolysis 0.0619817 2 20 
cellular cation homeostasis 0.063339568 4 284 
regulation of ERK1 and ERK2 cascade 0.063981924 3 111 
metal ion homeostasis 0.064852029 4 288 
cellular ion homeostasis 0.066330871 4 292 
extracellular matrix organization 0.066330871 4 292 
extracellular structure organization 0.066330871 4 293 
ERK1 and ERK2 cascade 0.07491573 3 120 
positive regulation of calcium ion transport into cytosol 0.094036985 2 26 
positive regulation of cytosolic calcium ion concentration 0.094313684 3 131 
*FDR: false discovery rate is greater than or equal to the probability that this is a false positive. 
Table 6:  The gene co-expression, shared domain, and interaction with PRSS1gene network 
Gene 1 Gene 2 Weight Network group 
F2R PRSS1 0.025958601 Co-expression 
PRSS2 PRSS1 0.03579626 Co-expression 
PRSS2 F2R 0.025450852 Co-expression 
KRT1 KRT2 0.021397633 Co-expression 
PRSS3 PRSS1 0.033738803 Co-expression 
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PRSS3 PRSS2 0.033134628 Co-expression 
ABCA4 PRSS1 0.020958284 Co-expression 
ABCA4 PRSS2 0.021833802 Co-expression 
ABCA4 PRSS3 0.020297663 Co-expression 
F2R F2RL1 0.01723061 Co-expression 
SERPINF2 KRT1 0.005162225 Co-expression 
PRSS3 PRSS2 0.030308522 Co-expression 
ABCA4 PARD3 0.018756393 Co-expression 
SERPINI1 F2RL1 0.018079963 Co-expression 
PRSS2 PRSS1 0.010663025 Co-expression 
KRT10 PRSS1 0.004751287 Co-expression 
KRT1 KRT2 0.017388888 Co-expression 
PRSS3 PRSS2 0.016354393 Co-expression 
ALB PRSS1 0.00978991 Co-expression 
TMPRSS15 PRSS1 0.009836646 Co-expression 
TMPRSS15 PRSS2 0.02349308 Co-expression 
ONECUT2 PRSS1 0.011885054 Co-expression 
ONECUT2 PRSS2 0.026482629 Co-expression 
ONECUT2 ALB 0.023143126 Co-expression 
ONECUT2 TMPRSS15 0.023315145 Co-expression 
KRT2 PARD3 0.00407993 Co-expression 
KRT2 F2RL3 0.002086929 Co-expression 
KRT1 PARD3 0.008348665 Co-expression 
KRT1 KRT2 0.001395255 Co-expression 
SERPINF2 PRSS2 0.020101048 Co-expression 
PRSS3 PRSS2 0.037385598 Co-expression 
KRT2 F2RL1 0.004147036 Co-expression 
KRT2 PARD3 0.004057049 Co-expression 
PRSS2 SERPINB8 0.013921468 Co-expression 
KRT1 PARD3 0.007636325 Co-expression 
KRT1 F2RL3 0.001890512 Co-expression 
KRT1 KRT2 0.000903638 Co-expression 
SERPINF2 KRT2 0.001538189 Co-expression 
PRSS3 SERPINB8 0.012880304 Co-expression 
PRSS3 PRSS2 0.01267024 Co-expression 
PRSS3 PRSS2 0.008046081 Co-expression 
ALB SERPINF2 0.012912146 Co-expression 
PRSS3 PRSS2 0.059784386 Co-expression 
ABCA4 PRSS1 0.021043219 Co-expression 
PRSS2 PRSS1 0.017638749 Co-expression 
PRSS3 PRSS1 0.010804671 Co-expression 
PRSS3 PRSS2 0.008761909 Co-expression 
ABCA4 TMPRSS15 0.014334416 Co-expression 
KRT10 KRT2 0.013258844 Co-expression 
KRT1 KRT2 0.012602167 Co-expression 
KRT1 KRT10 0.010437634 Co-expression 
PRSS3 PRSS2 0.020688048 Co-expression 
APP F2R 0.007284051 Co-expression 
KRT1 SERPINI1 0.011799906 Co-expression 
PRSS3 KRT2 0.01028535 Co-expression 
PRSS3 PRSS2 0.056584958 Co-expression 
SERPINB8 F2RL1 0.007467608 Co-expression 
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PRSS2 F2RL1 0.009436603 Co-expression 
PRSS3 F2RL1 0.0091086 Co-expression 
PRSS3 PRSS2 0.006767724 Co-expression 
PRSS2 SERPINB8 0.005437602 Co-expression 
CEP250 KRT1 0.007838975 Co-expression 
ALB APP 0.015414801 Co-expression 
PRSS2 F2RL1 0.011420856 Co-expression 
KRT10 KRT2 0.031353086 Co-expression 
KRT1 SERPINB8 0.017290482 Co-expression 
KRT1 KRT2 0.030572487 Co-expression 
ALB SERPINF2 0.011540175 Co-localization 
F2R F2RL3 0.004708032 Co-localization 
PRSS2 PRSS1 0.025921002 Co-localization 
KRT1 KRT10 0.025425598 Co-localization 
PRSS3 PRSS1 0.023983192 Co-localization 
PRSS3 PRSS2 0.023682926 Co-localization 
ALB SERPINF2 0.016614223 Co-localization 
TMPRSS15 PRSS1 0.02293591 Co-localization 
TMPRSS15 PRSS2 0.022705158 Co-localization 
TMPRSS15 PRSS3 0.022577295 Co-localization 
ONECUT2 PRSS1 0.022678863 Co-localization 
ONECUT2 PRSS2 0.022438433 Co-localization 
ONECUT2 PRSS3 0.02270408 Co-localization 
ONECUT2 TMPRSS15 0.026521208 Co-localization 
F2RL1 PRSS1 0.31954107 Pathway 
PARD3 PRSS1 0.15361263 Pathway 
F2RL3 PRSS1 0.1483753 Pathway 
F2R PRSS1 0.12154161 Pathway 
F2R F2RL3 0.03525233 Pathway 
PRSS2 F2RL1 0.31954107 Pathway 
PRSS2 PARD3 0.15361263 Pathway 
PRSS2 F2RL3 0.1483753 Pathway 
PRSS2 F2R 0.12154161 Pathway 
F2RL1 PRSS1 0.7365974 Pathway 
CEP250 PRSS1 0.08479679 Physical Interactions 
CEP250 DDX5 0.021656184 Physical Interactions 
ALB PRSS1 0.0910383 Physical Interactions 
ALB KRT10 0.0910383 Physical Interactions 
ALB KRT1 0.04481957 Physical Interactions 
ALB PRSS3 0.0910383 Physical Interactions 
DDX5 PRSS1 0.3375174 Physical Interactions 
KRT10 KRT2 0.37723482 Physical Interactions 
KRT1 KRT2 0.38693836 Physical Interactions 
KRT1 KRT10 0.20642798 Physical Interactions 
KRT2 PRSS1 0.28754097 Physical Interactions 
KRT10 PRSS1 0.24892193 Physical Interactions 
KRT10 KRT2 0.15666465 Physical Interactions 
KRT1 PRSS1 0.24077669 Physical Interactions 
KRT1 KRT2 0.15153825 Physical Interactions 
KRT1 KRT10 0.13118546 Physical Interactions 
SERPINB8 PRSS1 0.4951709 Physical Interactions 
SERPINF2 PRSS1 0.28534 Physical Interactions 
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APP PRSS1 0.41637108 Physical Interactions 
PRSS3 APP 0.13214332 Physical Interactions 
TMEM150B PRSS1 0.6281027 Physical Interactions 
ALB APP 0.0232307 Physical Interactions 
CEP250 APP 0.0232307 Physical Interactions 
SERPINB8 PRSS1 0.18267727 Physical Interactions 
APP PRSS2 0.030401716 Physical Interactions 
SERPINF2 PRSS1 0.0573582 Physical Interactions 
PRSS3 APP 0.05769704 Physical Interactions 
F2RL3 F2RL1 0.5863869 Predicted 
F2R F2RL1 0.17300643 Predicted 
KRT1 KRT2 0.15433232 Predicted 
SERPINI1 PRSS1 1 Predicted 
F2RL3 F2RL1 0.09312839 Shared protein domains 
F2R F2RL1 0.09312839 Shared protein domains 
F2R F2RL3 0.09312839 Shared protein domains 
SERPINB8 SERPINI1 0.028828265 Shared protein domains 
PRSS2 PRSS1 0.008043572 Shared protein domains 
KRT10 KRT2 0.008737453 Shared protein domains 
KRT1 KRT2 0.024351321 Shared protein domains 
SERPINF2 SERPINI1 0.028828265 Shared protein domains 
SERPINF2 SERPINB8 0.028828265 Shared protein domains 
PRSS3 PRSS1 0.010362946 Shared protein domains 
PRSS3 PRSS2 0.010437737 Shared protein domains 
TMPRSS15 PRSS1 0.006456545 Shared protein domains 
TMPRSS15 PRSS2 0.006503143 Shared protein domains 
F2RL3 F2RL1 0.00354377 Shared protein domains 
F2R F2RL1 0.00354377 Shared protein domains 
F2R F2RL3 0.00354377 Shared protein domains 
SERPINB8 SERPINI1 0.027777778 Shared protein domains 
PRSS2 PRSS1 0.009871521 Shared protein domains 
KRT10 KRT2 0.010121632 Shared protein domains 
KRT1 KRT2 0.018882168 Shared protein domains 
KRT1 KRT10 0.011125098 Shared protein domains 
SERPINF2 SERPINI1 0.027777778 Shared protein domains 
SERPINF2 SERPINB8 0.027777778 Shared protein domains 
PRSS3 PRSS1 0.009871521 Shared protein domains 
PRSS3 PRSS2 0.011186602 Shared protein domains 
Table 7: Maintenance outline of amino acids in PRSS1 
Residues 
position 
Residues 
CS Score 
normalized  
Color Residues Variety B/E 
1 M 0.211 7.3 M,N,P e 
4 L 0.361 6.3 M,S,L,I,H,F b 
CS Score normalized (1-4= variable, 5= average, 6-9= conserved). 
B/E: Buried (b) or Exposed (e) residue. 
Table 8: Shows variants consequences, impact and biotype features by VEP tool 
Uploaded 
variation 
SNP Location Consequence IMPACT BIOTYPE 
rs1366278558 M/R 7:142749486-142749486 start lost HIGH protein coding 
rs1366278558 - 7:142749486-142749486 
upstream gene 
variant 
MODIFIER retained intron 
rs1366278558 - 7:142749486-142749486 
non coding transcript 
exon variant 
MODIFIER retained intron 
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rs1366278558 M/R 7:142749486-142749486 start lost HIGH protein coding 
rs1366278558 M/R 7:142749486-142749486 
upstream gene 
variant 
MODIFIER protein coding 
rs1366278558 M/R 7:142749486-142749486 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs1366278558 M/R 7:142749486-142749486 start lost HIGH protein coding 
rs1366278558 M/R 7:142749486-142749486 
regulatory region 
variant 
MODIFIER open chromatin region 
rs767036052 L/P 7:142749495-142749495 missense variant MODERATE protein coding 
rs767036052 L/P 7:142749495-142749495 
upstream gene 
variant 
MODIFIER retained intron 
rs767036052 L/P 7:142749495-142749495 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs767036052 L/P 7:142749495-142749495 missense variant MODERATE protein coding 
rs767036052 L/P 7:142749495-142749495 
upstream gene 
variant 
MODIFIER protein coding 
rs767036052 L/P 7:142749495-142749495 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs767036052 L/P 7:142749495-142749495 missense variant MODERATE protein coding 
rs767036052 L/P 7:142749495-142749495 
regulatory region 
variant 
MODIFIER open chromatin region 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
start lost HIGH protein coding 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
start lost HIGH protein coding 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
upstream gene 
variant 
MODIFIER retained intron 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
upstream gene 
variant 
MODIFIER protein coding 
rs1366278558 M/R 
CHR_HSCHR7_2_CTG6:142790203-
142790203 
start lost HIGH protein coding 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
missense variant MODERATE protein coding 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
missense variant MODERATE protein coding 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
upstream gene 
variant 
MODIFIER retained intron 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
non coding transcript 
exon variant 
MODIFIER retained intron 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
upstream gene 
variant 
MODIFIER protein coding 
rs767036052 L/P 
CHR_HSCHR7_2_CTG6:142790212-
142790212 
missense variant MODERATE protein coding 
 
The predicted variants consequences are shown 
in (Tables 8), VEP reported regulatory 
consequences for many variants, including 6 
variants within a coding region, 2 variants within 
a non-coding region, 8 variants within upstream 
gene, 8 variants within noncoding transcript exon 
and 6 variant within start lost codon. in general 
any mutations within a coding region  will likely 
affect the protein function, while regulatory 
variants within non-coding genomic regions can 
greatly affect the expression of protein[67, 68], 
the SNPs in the upstream, 5'UTR region might 
affect transcription or translation process[69] 
In the light of our work, we agree with previous 
studies linking (P36R and V123M) with chronic 
pancreatitis  [70] . We also support the previous 
findings relating these mutations to certain forms 
of hereditary pancreatitis. (P36R and V123M) 
may be associated with pancreatic cancer along 
other types of cancer and  it has also been related  
in the past to familial Peutz-Jeghers syndrome 
[72-75], so this study can be used as a platform to 
develop large scale studies in the future in relation 
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to these disease . This study is the first 
computational analysis of PRSS1 gene which was 
based on functional and structural analysis while 
all earlier studies [31, 76] foxed on frequency and 
Whole exome sequencing. Furthermore, this 
study revealed two novel mutations (M1R, and 
L4P) that had a possible functional influence, 
which means that these SNPs could be used as 
diagnostic biomarkers for HP. Further wet lab 
studies are needed to confirm these results. 
4 Conclusion 
A total of two SNPs was predicted to have 
potential responsibility for the functional and 
structural alterations of PRSS1 gene. It is 
predicted from comparison of the results 
between various bioinformatics analysis tools; 
Out of a total of 911 SNPs in the PRSS1 gene, 
506 were nsSNPs; out of 506 nsSNPs, two were 
found to be the most deleterious nsSNPs (M1R 
and L4P) by eight functional analysis tools. 
Stability analysis results showed a dramatic 
decrease of the protein stability. These two SNPs 
may assist as diagnostic biomarkers for the 
prognosis of HP and may be used as a platform 
to develop large-scale studies in the future. 
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